💱 Part of Manera Treasury — Bloomberg-grade FX + credit + earnings + commodities at 1/40 the cost
Sentiment DNA Social & Narrative Intelligence · Manera
🧬 SentimentDNA · Social & Narrative Intelligence · $99/mo
See the story forming around a ticker — before the price does. Reddit + Yahoo + SEC · quality-weighted · AI narrative extraction. For investors, IR/PR teams, journalists. vs Bloomberg Social Velocity $24K/yr.
Subscribe Now →
← dashboard

ABBV

AbbVie · pharma · equity

Sentiment timeline · 30 days (weighted)

Posts · 14d
40
Bullish / Bearish
8 / 5
Narratives tracked
4
Sources
yahoo-finance 40

🎭 Narratives forming

Pipeline momentum in specialty pharma
AbbVie advancing neurological and dermatological programs with milestone payments and strong growth in key franchises like Skyrizi and Rinvoq.
momentum 0.78 · 5 mentions · 7d
Dividend fortress positioning
AbbVie positioned as a reliable high-yield dividend stock with strong financials, appealing to long-term income investors despite near-term price weakness.
momentum 0.72 · 6 mentions · 7d
Biosimilar expansion in emerging markets
AbbVie positioned to capture growth in biosimilar markets across Middle East and Africa driven by patent expiries and rising chronic disease prevalence.
momentum 0.55 · 2 mentions · 7d
GLP-1 weight-loss market underdog status
AbbVie attempting to enter the lucrative obesity treatment market but trailing Eli Lilly significantly in execution and market share.
momentum 0.45 · 1 mentions · 7d

🟢 Top bullish (quality-weighted)

🔴 Top bearish (quality-weighted)

Ask about ABBV